{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:34:56Z","timestamp":1792294496451,"version":"4.4.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine Reports"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.pmedr.2025.103244","type":"journal-article","created":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T14:51:19Z","timestamp":1757775079000},"page":"103244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Glucagon-like peptide-1 receptor agonists and suicide risk in individuals with diabetes and Cannabis use disorder"],"prefix":"10.1016","volume":"58","author":[{"given":"Yesh","family":"Dhruva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erick","family":"Messias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-I","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pmedr.2025.103244_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.103029","article-title":"Suicide and suicide attempt in users of GLP-1 receptor agonists: a nationwide case-time-control study","volume":"80","author":"Bezin","year":"2025","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.pmedr.2025.103244_bb0015","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jagp.2023.08.010","article-title":"The antidepressant effects of GLP-1 receptor agonists: a systematic review and Meta-analysis","volume":"32","author":"Chen","year":"2024","journal-title":"Am. J. Geriatr. Psychiatr."},{"issue":"4","key":"10.1016\/j.pmedr.2025.103244_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2025.103238","article-title":"Glucagon-like Peptide-1 receptor agonists, dual GIP\/GLP-1 receptor agonist tirzepatide and suicidal ideation and behavior: a systematic review of clinical studies and pharmacovigilance reports","volume":"19","author":"Di Stefano","year":"2025","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"issue":"6","key":"10.1016\/j.pmedr.2025.103244_bib81","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1080\/02699052.2019.1587000","article-title":"GLP-1\u2019s role in neuroprotection: a systematic review","volume":"33","author":"Erbil","year":"2019","journal-title":"Brain Inj"},{"key":"10.1016\/j.pmedr.2025.103244_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2020.614884","article-title":"Can GLP-1 be a target for reward system related disorders? A qualitative synthesis and systematic review analysis of studies on palatable food, drugs of abuse, and alcohol","volume":"14","author":"Eren-Yazicioglu","year":"2021","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.pmedr.2025.103244_bb0030","doi-asserted-by":"crossref","DOI":"10.1111\/jan.16074","article-title":"Suicide death, suicidal ideation and suicide attempt in patients with diabetes: a systematic review and meta-analysis","author":"Fan","year":"2024","journal-title":"J. Adv. Nurs."},{"key":"10.1016\/j.pmedr.2025.103244_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-025-03234-5","article-title":"The interface of depression and diabetes: treatment considerations","volume":"15","author":"Fanelli","year":"2025","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pmedr.2025.103244_bb0040","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay8071","article-title":"GABA neurons in the nucleus tractus solitarius express GLP-1 receptors and mediate anorectic effects of liraglutide in rats","volume":"12","author":"Fortin","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.pmedr.2025.103244_bb0045","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay8071","article-title":"GABA neurons in the nucleus tractus solitarius express GLP-1 receptors and mediate anorectic effects of liraglutide in rats","volume":"12","author":"Fortin","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.pmedr.2025.103244_bb0050","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.2337\/dc24-0597","article-title":"Past-month Cannabis use among adults with diabetes in the U.S., 2021\u20132022","volume":"47","author":"Han","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pmedr.2025.103244_bb0060","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S2213-8587(15)00134-5","article-title":"The link between depression and diabetes: the search for shared mechanisms","volume":"3","author":"Moulton","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.pmedr.2025.103244_bb0065","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/1753-0407.12958","article-title":"Lifetime marijuana use in relation to insulin resistance in lean, overweight, and obese US adults","volume":"12","author":"Ngueta","year":"2020","journal-title":"J. Diabetes"},{"key":"10.1016\/j.pmedr.2025.103244_bb0070","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.amjmed.2013.03.002","article-title":"The impact of marijuana use on glucose, insulin, and insulin resistance among US adults","volume":"126","author":"Penner","year":"2013","journal-title":"Am. J. Med."},{"key":"10.1016\/j.pmedr.2025.103244_bb0075","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/jamainternmed.2024.4369","article-title":"GLP-1 receptor agonist use and risk of suicide death","volume":"184","author":"Ueda","year":"2024","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.pmedr.2025.103244_bb0080","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jad.2024.08.071","article-title":"Metformin treatment improves depressive symptoms associated with type 2 diabetes: a 24-week longitudinal study","volume":"365","author":"Yang","year":"2024","journal-title":"J. Affect. Disord."}],"container-title":["Preventive Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211335525002839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211335525002839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T05:22:17Z","timestamp":1758604937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211335525002839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":15,"alternative-id":["S2211335525002839"],"URL":"https:\/\/doi.org\/10.1016\/j.pmedr.2025.103244","relation":{},"ISSN":["2211-3355"],"issn-type":[{"value":"2211-3355","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucagon-like peptide-1 receptor agonists and suicide risk in individuals with diabetes and Cannabis use disorder","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pmedr.2025.103244","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103244"}}